Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Axogen (AXGN) over the last 14 years, with Q3 2025 value amounting to $3000.0.

  • Axogen's Gains from Investment Securities rose 5000.0% to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15000.0, marking a year-over-year increase of 12631.58%. This contributed to the annual value of $10000.0 for FY2024, which is 11785.71% up from last year.
  • According to the latest figures from Q3 2025, Axogen's Gains from Investment Securities is $3000.0, which was up 5000.0% from $7000.0 recorded in Q2 2025.
  • Axogen's 5-year Gains from Investment Securities high stood at $11000.0 for Q2 2023, and its period low was -$63000.0 during Q4 2023.
  • For the 5-year period, Axogen's Gains from Investment Securities averaged around -$421.05, with its median value being $3000.0 (2021).
  • Over the last 5 years, Axogen's Gains from Investment Securities had its largest YoY gain of 120000.0% in 2023, and its largest YoY loss of 220000.0% in 2023.
  • Quarter analysis of 5 years shows Axogen's Gains from Investment Securities stood at $3000.0 in 2021, then changed by 0.0% to $3000.0 in 2022, then plummeted by 2200.0% to -$63000.0 in 2023, then skyrocketed by 106.35% to $4000.0 in 2024, then dropped by 25.0% to $3000.0 in 2025.
  • Its Gains from Investment Securities was $3000.0 in Q3 2025, compared to $7000.0 in Q2 2025 and $1000.0 in Q1 2025.